Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors.
about
The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their AlkalinizationKnocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma.Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumorsThymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulationCharacterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma.Whole genome and transcriptome sequencing of a B3 thymoma.Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors.Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analyses.Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential.Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors.Expression of cell cycle and apoptosis regulators in thymus and thymic epithelial tumors.PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors.Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic TargetsIncreased cFLIP expression in thymic epithelial tumors blocks autophagy via NF-κB signalling.A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.Betulinic acid induces apoptosis and ultrastructural changes in MDA-MB-231 breast cancer cells.Novel Agents in the Treatment of Thymic Malignancies.[Thymomas].
P2860
Q27318794-F96EC523-CD60-488F-8094-2285A05366E1Q33583605-D3D23306-10F4-41C8-AD94-1B6F8D5988C9Q33645601-45F6E16D-5429-451D-BBFD-C3B25FC65045Q33655180-21D319EC-4768-4329-8320-3E74B4E6B063Q33691435-6E321093-925F-4705-AE7E-180119D65833Q34663810-823D7C83-AA53-4ABF-811F-5DAF72FD6C63Q36778107-D5C3A799-9CE9-4F03-A5FE-E8F2B0CB7B8DQ37132244-F0ABAC0D-3F88-4F5E-A315-3CD19B607CEDQ37707683-FCAF246D-30C2-448C-A61E-ADE0F8586618Q38269843-C12BF25B-ABFA-4059-9614-979A28F598CCQ38385580-3AB11AB6-F505-4AC2-B056-E913532B0F68Q38775158-14E4A601-2E8A-4125-A392-812209AD12CFQ41021890-045EC6B7-70CE-4339-9085-2500CCCC9095Q45491251-C99C01F4-C10E-44C6-BE2D-713F4C9EDB59Q47142579-501AC4A5-B391-4FBD-8D8D-C04CDAD75EA7Q47343974-524E2885-7287-4894-BA28-8CB381A8D2FEQ48696917-BD98A036-AE07-4204-AE79-B74067F31D58Q52955529-DFD65F99-9AC9-426B-B903-FB88F6E91613
P2860
Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Copy number aberrations of BCL ...... H in thymic epithelial tumors.
@ast
Copy number aberrations of BCL ...... H in thymic epithelial tumors.
@en
type
label
Copy number aberrations of BCL ...... H in thymic epithelial tumors.
@ast
Copy number aberrations of BCL ...... H in thymic epithelial tumors.
@en
prefLabel
Copy number aberrations of BCL ...... H in thymic epithelial tumors.
@ast
Copy number aberrations of BCL ...... H in thymic epithelial tumors.
@en
P2093
P2860
P50
P356
P1476
Copy number aberrations of BCL ...... GH in thymic epithelial tumors
@en
P2093
K J Killian
P A Zucali
P S Meltzer
S M Steinberg
P2860
P356
10.1038/CDDIS.2012.92
P577
2012-07-19T00:00:00Z